Original Research

Pediatric Acute Lymphoblastic Leukemia in Rawalpindi

DOI https://doi.org/10.70302/jpsim.v5i3.2455
Received: 16 Feb 2024 Accepted: 06 Aug 2024 Published Online: 30 Aug 2024

Abstract

Objective

To identify the incidences of ALL, it’s Diagnostic, clinical and its prognostic aspect from CMH Rawalpindi hospital Pakistan

Methods

Diagnosis and screening for ALL was done at CMH Rawalpindi from 2010-2021. During this time, 981 individuals under the age of 19 who had recently been diagnosed with acute lymphoblastic leukemia. Cytological, immunophenotypic, and cytogenetic criteria were employed to diagnose. Chi-square and Fisher's exact tests assessed prognostic factor associations.

Results

The collected data from 2010-2021, showed that Males predominated the incidence rate 626 (63.8%), average diagnostic age was 6.3-0.5 years. Results showed that 207(21.10%) were children less than 3 years old, 587(59.80%) were between 3-10 years old. While 187(19%) were above age of 10. After statistical analysis, patients at standard risk were found to be (496)50.5% while 485(49.5%) were at high risk. The collected data reported prevalence of ALL in (850)86.6% patients while 131(13.3%) patients were diagnosed with Albl. The survival rate of patients having disease and that of survival rate with disease free conditions was found in 655(66.7%) and 326(33.3%) patients respectively. Patients with normal nutritional status 726(74%), with moderate eating 165(16.80%) and eating severely 90(9.2%) was reported and analyzed.

Conclusion

ALL is found to be one of threat in young children and adolescence. There is a threat of relapse even after recovery from ALL when treated specifically in adolescence. Early prognosis and diagnosis of ALL is necessary to mitigate its effects and to avoid its recurrence. Health authorities in this regard should provide the required facilities to overcome this menace.

Keywords
Acute Lymphoblastic Leukemia Malignancy T-ALL Standard risk High risk.

How to Cite This Article

Ikramullah I, Saleem S, Saad AB, Rehman N, Mufti MZ, Malik SN. Pediatric Acute Lymphoblastic Leukemia in Rawalpindi. J Pak Soc Intern Med. 2024;5(3):635–639. doi:10.70302/jpsim.v5i3.2455

⭳ Download PDF

Conflict of Interest

All authors declare no competing interests.

Disclosed in accordance with ICMJE and COPE guidelines.

Funding

No specific funding was received for this research.

Funder information follows the Crossref Funder Registry standard.

References

  1. Bhatia S, Robison LLJOoI, Childhood. Philadelphia PSE. Epidemiology of leukemia in childhood. 2009:3-25.
  2. Pui C-H, Pei D, Campana D, Bowman WP, Sandlund JT, Kaste SC, et al. Improved prognosis for older adolescents with acute lymphoblastic leukemia. J Clin Oncol 2011;29(4):386.
  3. Coustan-Smith E, Sancho J, Behm FG, Hancock ML, Razzouk BI, Ribeiro RC, et al. Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemia. Blood. 2002;100(1):52-8.
  4. Moricke A, Reiter A, Zimmermann M, Gadner H, Stanulla M, Dordelmann M, et al. Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: Treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial all-bfm 95. Rand Control Trial. 2008;11(9): 4477-89.
  5. Friedmann AM, Weinstein HJJTo. The role of prognostic features in the treatment of childhood acute lymphoblastic leukemia. Oncologist. 2000;5(4):321-8.
  6. Borowitz MJ, Devidas M, Hunger SP, Bowman WP, Carroll AJ, Carroll WL, et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: A children's oncology group study. Blood. 2008;111(12):5477-85.
  7. Arico M, Valsecchi MG, Rizzari C, Barisone E, Biondi A, Casale F, et al. Long-term results of the aieop-all-95 trial for childhood acute lymphoblastic leukemia: Insight on the prognostic value of DNA index in the framework of berlin-frankfurt-muenster–based chemotherapy. J Clin Oncol. 2008;26(2):283-9.
  8. Leite EP, Muniz MTC, Azevedo AdCACd, Souto FR, Maia ÂCL, Gondim CMdF, et al. Fatores prognósticos em crianças e adolescentes com leucemia linfóide aguda. Rev Bras Saude Mater Infant. 2007;7(4):413-21.
  9. Pereira WV. Aspectos epidemiológicos, biotipologia e evolução do tratamento da leucemia linfocítica aguda na infância e adolescência no rio grande do sul: Universidade de São Paulo; 2010.
  10. Schrappe M, Camitta B, Pui CJL. Long-term results of large prospective trials in childhood acute lymphoblastic leukemia. Leukemia. 2000;14(12):2193-4.
  11. Goldberg JM, Silverman LB, Levy DE, Dalton VK, Gelber RD, Lehmann L, et al. Childhood t-cell acute lymphoblastic leukemia: The dana-farber cancer institute acute lymphoblastic leukemia consortium experience. J Clin Oncol. 2003;21(19):3616-22.
  12. Silverman LB, Gelber RD, Dalton VK, Asselin BL, Barr RD, Clavell LA, et al. Improved outcome for children with acute lymphoblastic leukemia: Results of dana-farber consortium protocol 91-01. Blood. 2001;97(5):1211-8.
  13. Dastugue N, Suciu S, Plat G, Speleman F, Cavé H, Girard S, et al. Hyperdiploidy with 58-66 chromosomes in childhood b-acute lymphoblastic leukemia is highly curable: 58951 clg-eortc results. Blood. 2013;121(13):2415-23.
  14. Stock W, La M, Sanford B, Bloomfield CD, Vardiman JW, Gaynon P, et al. What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of children's cancer group and cancer and leukemia group b studies. Blood. 2008;112(5):1646-54.
  15. Manabe A, Ohara A, Hasegawa D, Koh K, Saito T, Kiyokawa N, et al. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: The tokyo children’s cancer study group study l99-15. Hematologica. 2008;93(8):1155-60.
  16. Brandalise SR. Prognostic value of day 8 peripheral blood responce for children with acute lymphocytic leukemia. Gene technology: Stem cell and leukemia research: Springer; 1996. p. 421-8.
  17. Sousa DWLd, Ferreira FVdA, Félix FHC, Lopes MVdOJRbdheh. Acute lymphoblastic leukemia in children and adolescents: Prognostic factors and analysis of survival. Rev Brasil Hematol Hemoter. 2015;37(7):223-9.

Reference list indexed for Google Scholar and ResearchGate. DOI links resolve via doi.org.

CC BY CC BY 4.0 This article is published under the Creative Commons Attribution 4.0 International License. May be shared and adapted with attribution. © 2024 Journal of Pakistan Society of Internal Medicine.